newsfilter
← Latest News
PR Newswire·

/C O R R E C T I O N -- Decoy Therapeutics, Inc/

Decoy Therapeutics, Inc. (NASDAQ: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™) to target major respiratory and...